A detailed history of Guggenheim Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Guggenheim Capital LLC holds 124,704 shares of ABT stock, worth $14.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
124,704
Previous 151,395 17.63%
Holding current value
$14.3 Million
Previous $15.7 Million 9.62%
% of portfolio
0.1%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $2.67 Million - $3.15 Million
-26,691 Reduced 17.63%
124,704 $14.2 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $1.05 Million - $1.17 Million
-10,443 Reduced 6.45%
151,395 $15.7 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $498,096 - $550,126
4,548 Added 2.89%
161,838 $18.4 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $135,194 - $165,489
1,499 Added 0.96%
157,290 $17.3 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $2.09 Million - $2.51 Million
-21,919 Reduced 12.33%
155,791 $15.1 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $3.8 Million - $4.24 Million
37,719 Added 26.94%
177,710 $19.4 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $4.2 Million - $4.95 Million
43,390 Added 44.92%
139,991 $14.2 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $1.95 Million - $2.29 Million
20,553 Added 27.03%
96,601 $10.6 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $1.07 Million - $1.24 Million
11,068 Added 17.03%
76,048 $7.36 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $7.35 Million - $8.89 Million
-72,040 Reduced 52.58%
64,980 $7.06 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $432,249 - $527,100
-3,791 Reduced 2.69%
137,020 $16.2 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $3.76 Million - $4.61 Million
32,570 Added 30.09%
140,811 $19.8 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $495,338 - $547,988
4,246 Added 4.08%
108,241 $12.8 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $2.51 Million - $2.96 Million
-23,738 Reduced 18.58%
103,995 $12.1 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $857,876 - $1.01 Million
-7,882 Reduced 5.81%
127,733 $15.3 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $749,070 - $816,272
-7,134 Reduced 5.0%
135,615 $14.8 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $1.35 Million - $1.64 Million
-14,704 Reduced 9.34%
142,749 $15.5 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $1.62 Million - $2.08 Million
-21,219 Reduced 11.88%
157,453 $14.4 Million
Q1 2020

Jun 02, 2020

BUY
$62.82 - $91.86 $377,485 - $551,986
6,009 Added 3.48%
178,672 $14.1 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $1.12 Million - $1.25 Million
-14,245 Reduced 7.62%
172,663 $15 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $2.81 Million - $3.05 Million
-34,382 Reduced 15.54%
186,908 $15.6 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $727,633 - $848,640
-9,984 Reduced 4.32%
221,290 $18.6 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $2.6 Million - $3.15 Million
39,307 Added 20.48%
231,274 $18.5 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $6.32 Million - $7.16 Million
-96,381 Reduced 33.43%
191,967 $13.9 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $4.07 Million - $4.91 Million
66,912 Added 30.22%
288,348 $21.2 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $50.2 Million - $55.4 Million
-872,646 Reduced 79.76%
221,436 $13.5 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $14.6 Million - $16.5 Million
-259,062 Reduced 19.15%
1,094,082 $65.6 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $19.3 Million - $20.6 Million
358,637 Added 36.06%
1,353,144 $77.2 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $47.8 Million - $53.3 Million
994,507
994,507 $53.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.